CBD Stocks

Consumers Clamor for CBD as More Novel Uses are Purported

Consumers Clamor for CBD as More Novel Uses are Purported

NEW YORK, Feb. 11, 2020 /PRNewswire/ — Earlier in 2018, the Farm Bill restored industrial hemp to nationwide legal production for the first time since World War II. Removing hemp from the Controlled Substances Act of 1970 (CSA) also helped create a...

CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge

You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.

Stick with the Recent Rally in Canopy Growth Stock

Stick with the Recent Rally in Canopy Growth Stock

Amid a plethora of issues ranging from leadership changes to sluggish demand to margin erosion, shares of Canada’s biggest cannabis producer, Canopy Growth (NYSE:CGC), plunged in the second half of 2019, falling from over $50 a share, to under $14. But, there’s reason...

CBD’s Status Continues to Grow in the Eyes of Consumers

CBD’s Status Continues to Grow in the Eyes of Consumers

NEW YORK, Feb. 6, 2020 /PRNewswire/ — Each year, more and more countries are moving towards partial or even full legalization of cannabis products. In fact, several regions around the world have either decriminalized or legalized the use of recreational...